Amgen Inc (AMGN)
294.52
+4.62
(+1.59%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
+0.01
(+0.00%)
After-Hours: 20:00
Amgen Cash from Operations (Quarterly): 3.571B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.571B |
| June 30, 2024 | 2.459B |
| March 31, 2024 | 689.00M |
| December 31, 2023 | 538.00M |
| September 30, 2023 | 2.76B |
| June 30, 2023 | 4.109B |
| March 31, 2023 | 1.064B |
| December 31, 2022 | 2.649B |
| September 30, 2022 | 2.978B |
| June 30, 2022 | 1.93B |
| March 31, 2022 | 2.164B |
| December 31, 2021 | 2.808B |
| September 30, 2021 | 2.418B |
| June 30, 2021 | 1.931B |
| March 31, 2021 | 2.104B |
| December 31, 2020 | 2.153B |
| September 30, 2020 | 3.368B |
| June 30, 2020 | 2.842B |
| March 31, 2020 | 2.134B |
| December 31, 2019 | 2.514B |
| September 30, 2019 | 3.377B |
| June 30, 2019 | 1.414B |
| March 31, 2019 | 1.845B |
| December 31, 2018 | 3.194B |
| September 30, 2018 | 3.273B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.102B |
| March 31, 2018 | 2.727B |
| December 31, 2017 | 3.012B |
| September 30, 2017 | 3.454B |
| June 30, 2017 | 2.326B |
| March 31, 2017 | 2.385B |
| December 31, 2016 | 3.10B |
| September 30, 2016 | 2.662B |
| June 30, 2016 | 2.677B |
| March 31, 2016 | 1.915B |
| December 31, 2015 | 2.073B |
| September 30, 2015 | 2.892B |
| June 30, 2015 | 3.284B |
| March 31, 2015 | 1.482B |
| December 31, 2014 | 2.842B |
| September 30, 2014 | 2.741B |
| June 30, 2014 | 2.227B |
| March 31, 2014 | 1.142B |
| December 31, 2013 | 1.835B |
| September 30, 2013 | 1.807B |
| June 30, 2013 | 1.60B |
| March 31, 2013 | 1.049B |
| December 31, 2012 | 812.00M |
| September 30, 2012 | 1.723B |
| June 30, 2012 | 2.375B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
538.00M
Minimum
Dec 2023
4.109B
Maximum
Jun 2023
2.359B
Average
2.438B
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 7.993B |
| Eli Lilly and Co | 3.712B |
| Merck & Co Inc | 9.291B |
| Regeneron Pharmaceuticals Inc | 1.291B |
| Viking Therapeutics Inc | -21.96M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -210.00M |
| Cash from Financing (Quarterly) | -3.651B |
| Free Cash Flow | 6.283B |
| Free Cash Flow Per Share (Quarterly) | 6.114 |
| Free Cash Flow to Equity (Quarterly) | 5.561B |
| Free Cash Flow to Firm (Quarterly) | 4.022B |
| Free Cash Flow Yield | 3.96% |